E*dwardsiella tarda* is a motile, facultatively anaerobic, Gram-negative rod that is categorized as a member of the family Enterobacteriaceae. The genus *Edwardsiella* was first recognized by Trabulsi et al ([@b1-jidmm-26-313]) in 1962, followed by a description of *E tarda* in the mid-1960s. These organisms have successively been named the "Bartholomew group" by King and Adler ([@b2-jidmm-26-313]), the "Asakusa group" by Sakazaki ([@b3-jidmm-26-313]) and "*Edwardsiella*" by Ewing et al ([@b4-jidmm-26-313]).

*E tarda* is typically isolated from fresh or brackish water environments such as river mouths. It has also been isolated from the intestines of humans (after eating fresh water food sources such as catfish \[5\] or eels \[6\]) and from animals, including reptiles and freshwater fish.

*E tarda* rarely causes infections in humans. The colonization rate in humans ranges from 0.0073% in the Japanese ([@b7-jidmm-26-313]) to 1% in Panamanians ([@b8-jidmm-26-313]). Approximately 80% of *E tarda* infections in humans are characterized as gastroenteritis and *E tarda* is primarily isolated from stool samples. Extraintestinal infections, such as endocarditis, empyema, hepatobiliary infections, peritonitis, intra-abdominal abscesses, osteomyelitis, wound infections and meningitis, have been reported less frequently. While *E tarda* bacteremia (ETB) occurs relatively rarely (\<5%), it can be fatal in humans ([@b9-jidmm-26-313]). However, little is known about the clinical epidemiology of ETB. Therefore, we aimed to document the clinical epidemiology of ETB, including independent risk factors associated with death, the geographical and seasonal distributions, as well as environmental and dietary risks, based on previous reports and recent clinical cases of ETB at our institution (Tokyo Women's Medical Univeristy \[TWMU\] Hospital \[Tokyo, Japan\]).

METHODS
=======

A retrospective, observational, case control study was performed. The present analysis comprised literature and retrospective chart reviews. A search was conducted for case reports and case series involving ETB, published between January 1968 and December 2013, with the PubMed MEDLINE and Japanese Medical Abstracts Society ICHUSHI ([www.jamas.or.jp](www.jamas.or.jp)) databases using the following keywords: "*Edwardsiella tarda*", "*E tarda*" and "infection". An episode of ETB was defined as ≥1 positive blood cultures yielding *E tarda* from the same patient. Results meeting the following criteria were included: published case reports or abstracts from scientific meetings; patients of any age; and articles published in any language including English, French, Spanish and Japanese. Exclusion criteria included: negative blood culture; no description of *E tarda* infection; animal cases; experimental studies; and review articles.

In addition, the medical records of patients, regardless of age, with ETB admitted to the TWMU (a 1423-bed university hospital in Tokyo, Japan) between April 2000 and December 2013, were included in the retrospective chart review.

The following data were obtained from both published and TWMU-admitted cases that fulfilled the inclusion criteria: age; sex; underlying disease; antibiotic treatment; complications related to the ETB; geographical area; month of ETB onset; history of exposure to environmental risk factors; dietary history to include dietary risk factors; and crude mortality after ETB within 90 days. The case definition for survival required a report of whether the patient survived, or no report of death, in published articles or medical records from cases at TWMU. During the study period, 112,796 blood samples were obtained under sterile conditions and were processed using BACTEC 9240 (Becton Dickinson Diagnostic Instrument Systems, USA) until March 11, 2011, and BacT/ALERT 3D (bioMérieux, France) from April 2011 onward. Strains of *E tarda* were identified using MicroScan WalkAway 96si (Siemens, Germany). The five cases of ETB identified were included in the present study. The species identification of *E tarda* was also confirmed using matrix-assisted laser desorption ionization--time of flight mass spectrometry (Microflex LT with MALDI-Biotyper version 3.1, Bruker Daltonik, Germany). Susceptibility of *E tarda* isolated from blood cultures was tested retrospectively in accordance with the standards of the Clinical and Laboratory Standards Institute using E-test (bioMérieux, France).

Continuous data were compared using a *t* test and categorical data were compared using Fisher's exact tests; P\<0.05 was considered to be statistically significant. Multivariate analyses were used to determine the independent risk factors associated with mortality using forward stepwise logistic regression. All variables with P\<0.1 in univariate analyses were entered into the multivariate model. Statistical analyses were performed using R version 3.0.3 ([www.r-project.org](www.r-project.org)).

The study protocol was approved by the TWMU Hospital Medical Ethics Committee (No. 3052).

RESULTS
=======

The literature search resulted in 234 articles from the PubMed MEDLINE database and 68 articles from the ICHUSHI database, published between January 1968 and December 2013. Of these, 202 and 54 publications were excluded, according to inclusion criteria, from the PubMed MEDLINE and ICHUSHI databases, respectively. The resulting 46 publications, published between 1968 and 2013, were retrieved from the English (n=30) ([@b8-jidmm-26-313]--[@b37-jidmm-26-313]), French (n=1) ([@b38-jidmm-26-313]), Spanish (n=1) ([@b39-jidmm-26-313]) and Japanese (n=14) literature ([@b40-jidmm-26-313]--[@b53-jidmm-26-313]). A total of 72 cases were described in the retrieved publications and five cases diagnosed at the TWMU were also included, resulting in 77 cases for analysis.

The mean age of the patients was 61 years (range two days to 101 years) and 30 cases (30 of 77 \[39%\]) involved women. Underlying diseases included cancer (29 of 77 \[37.6%\]); hepatobiliary cancer (17 of 77 \[20.8%\]) and liver cirrhosis (13 of 77 \[16.8%\]). Six (6.5%) cases involved neonatal patients. Thirteen (16.9%) cases occurred in healthy individuals without any underlying disease and there were 35 (45.5%) cases of uncomplicated ETB. Eighteen (23.4%) cases involved soft tissue infections, 24.7% involved diarrhea, 13.0% involved liver abscess and 3.9% involved meningitis. Despite appropriate antimicrobial therapy, the overall mortality rate was 44.6% (33 of 74, no mortality data available for three cases \[14,46,49\]); however, this rate increased to 61.1% (11 of 18) for patients with soft tissue infections.

Treatment using the following antimicrobial agents was described in 51 cases (66.2%): cephalosporin (n=26), penicillin (n=19) and carbapenems (n=8). Although no significant differences were found with respect to age, sex, complications of ETB, geographical area or season of onset among cases in which the patient died compared with cases in which the patient survived, liver cirrhosis (OR 12.0 \[95% CI 2.46 to 58.6\]; P*=*0.00213) was considered to be an independent risk factor associated with death in multivariate analyses ([Table 1](#t1-jidmm-26-313){ref-type="table"}). Antibiotic susceptibility of the *E tarda* strains that were isolated from the blood cultures is summarized in [Table 2](#t2-jidmm-26-313){ref-type="table"}. Six cases in the literature reported susceptibility to ampicillin, cefazolin, imipenem, levofloxacin and gentamicin, in cases in which each drug minimum inhibitory concentrations were measured ([@b13-jidmm-26-313],[@b18-jidmm-26-313],[@b39-jidmm-26-313],[@b41-jidmm-26-313],[@b42-jidmm-26-313],[@b51-jidmm-26-313]--[@b53-jidmm-26-313]). Reduced susceptibility to colistin was found in four of five strains (80%) at the TWMU and two of two strains ([@b13-jidmm-26-313],[@b18-jidmm-26-313]) in the literature. Reported environmental risks included direct exposure to fresh or brackish water (lacerated forearm after a fall into brackish water \[28\] and fishing \[28,36\]), soil (farming \[8\] and gardening \[12\]) and animal feces (working in a zoo \[20\]). The parents of two neonatal cases were exposed to fresh water; the father from one case was a dock maintenance worker at a lake and his wife participated in a baptism involving immersion in a lake while pregnant, and a mother from another case washed clothes in a river resulting in confirmed maternal colonization ([@b29-jidmm-26-313],[@b50-jidmm-26-313]). Reported dietary risks included exposure to raw fish/sushi ([@b48-jidmm-26-313],[@b50-jidmm-26-313],[@b51-jidmm-26-313]) (TWMU-5 in [Table 2](#t2-jidmm-26-313){ref-type="table"}), raw meat ([@b27-jidmm-26-313]), ceviche during a trip to Ecuador ([@b45-jidmm-26-313]) and unpasteurized goat's milk ([@b46-jidmm-26-313]). The geographical distribution of ETB is shown in [Figure 1](#f1-jidmm-26-313){ref-type="fig"}. The most frequently reported geographical area of ETB cases was Japan (35 of 77 \[45.5%\]) ([@b21-jidmm-26-313],[@b32-jidmm-26-313],[@b37-jidmm-26-313],[@b40-jidmm-26-313]--[@b53-jidmm-26-313]) (TWMU-1, −2, −3, −4, −5 in [Table 2](#t2-jidmm-26-313){ref-type="table"}), followed by the United States (US) (12 of 77 \[15.6%\]) and the Republic of China (Taiwan) (10 of 77 \[13.0%\]). Five of 12 (41.6%) cases from the US occurred in states located around the Gulf of Mexico (Louisiana, n=2 \[12,32\]; Florida, n=1 \[15\]; Texas, n=1 \[18\]; and Mississippi, n=1 \[24\]). Of the cases from the US, 66.7% (eight of 12) occurred in states by the ocean (five cases near the Gulf of Mexico ([@b12-jidmm-26-313],[@b15-jidmm-26-313],[@b18-jidmm-26-313],[@b24-jidmm-26-313],[@b32-jidmm-26-313]); New York, n=2 \[22,33\]; and California, n=1 \[13\]). No reports of ETB cases in the southern hemisphere were found in the present review. The seasonal distribution of ETB is shown in [Figure 2](#f2-jidmm-26-313){ref-type="fig"}. The majority of the cases that provided a description of the time of onset (18 of 22 \[81.8%\]) ([@b10-jidmm-26-313],[@b12-jidmm-26-313],[@b13-jidmm-26-313],[@b15-jidmm-26-313],[@b16-jidmm-26-313],[@b18-jidmm-26-313],[@b21-jidmm-26-313],[@b25-jidmm-26-313],[@b28-jidmm-26-313],[@b33-jidmm-26-313],[@b38-jidmm-26-313],[@b40-jidmm-26-313]--[@b42-jidmm-26-313],[@b45-jidmm-26-313],[@b50-jidmm-26-313],[@b51-jidmm-26-313]) (TWMU-1, −2, −3, −4, −5 in [Table 2](#t2-jidmm-26-313){ref-type="table"}) occurred during the northern hemisphere summer and autumn months (June to November).

DISCUSSION
==========

To our knowledge, the present study was the first and largest multi-language review of ETB. The results indicate that the overall mortality related to ETB is 44.6%, and ETB may be more likely to occur in the humid and subtropical climates of Eastern Asia and near the Gulf of Mexico in the US, particularly during summer and autumn months. Furthermore, environmental and dietary risk factors, such as exposure to brackish water and raw food consumption, may play a role in ETB.

ETB occurs infrequently (\<5%) ([@b9-jidmm-26-313]), and the risk factors are not well established. Investigating similarities with other species may provide some clues regarding the mechanisms related to ETB. Previous case series suggest that up to 50% of ETB patients also had hepatobiliary diseases, including alcoholic cirrhosis ([@b9-jidmm-26-313]). Interestingly, the authors indicated that conditions resulting in iron overload, such as cirrhosis, sickle cell anemia, leukemia and the neonatal state, are also considered to be risk factors for ETB ([@b9-jidmm-26-313]). In the present analysis, 66.2% of the cases involved hepatobiliary diseases, including cancer. Twenty-one (27.3%) of these cases involved gallbladder stones with recurrent episodes of cholecystitis. The rate of underlying diseases may be higher in ETB than in other *E tarda* infections; this may indicate that the presence of underlying disease increases the risk for developing ETB. However, the results of our multivariate analyses suggest, for the first time, that liver cirrhosis is an independent risk factor associated with death in ETB. Cholecystitis with gallbladder stones may increase the risk for ETB in a way similar to that of human typhoid fever. Moreover, the overall rate of underlying diseases in ETB may be higher than in other *E tarda* infections, potentially indicating that the presence of underlying disease increases the risk for ETB and subsequent high mortality from ETB.

In addition, reservoir-related *Aeromonas* species are similar to *E tarda*. Both can cause a wide spectrum of diseases among warm- and cold-blooded animals, including fish, reptiles, amphibians, mammals and humans. Population sizes of both species can grow quite large, generally peaking in the warmer temperatures of the summer months in temperate freshwater lakes and chlorinated drinking water, and have been associated with contact wtih reptiles, including those kept as pets ([@b54-jidmm-26-313]). *Vibrio vulnificus* can also cause severe disseminated infection associated with exposure to seawater and brackish water. Severe *V vulnificus* infections in humans are also responsible for liver cirrhosis. Therefore, clinical characteristics of *E tarda* infections in humans resemble those of *Aeromonas*, typhoid fever and *V vulnificus* infections, and share similar environmental risks. It is well known that necrotizing fasciitis type 3, which is known as a marine infection and can be fatal within 48 h, is caused by *Vibrio* or *Aeromonas* species. Therefore, it should be recognized that *E tarda* can also result in necrotizing fasciitis type 3. In addition, previous reports indicate that the mortality rate of ETB is nearly 50%, which is similar to that of *V vulnificus* ([@b55-jidmm-26-313]) or severe infections caused by *Aeromonas* species ([@b56-jidmm-26-313],[@b57-jidmm-26-313]).

*E tarda* infections, including ETB, are considered to be foodborne. Despite this, dietary risk factors for ETB have not been well established or documented. In addition, most of the cases of ETB are suspected to occur endogenously through primary colonization and infection in the human intestinal tract. However, documented *E tarda* infections in humans have resulted from the consumption of infected or contaminated food such as fish ([@b58-jidmm-26-313]). According to the Food and Agriculture Organization of the United Nations Statisitcs Division (FAOSTAT) Food Balance Sheet 2006 (<http://faostat.fao.org/>), Japan has one of the world's highest per capita seafood consumption rates. *E tarda* has been isolated from raw flounder in Japanese fish farms ([@b58-jidmm-26-313]). Interestingly, *E tarda* has been reported to result in a 60% to 90% mortality rate among Japanese eels ([@b59-jidmm-26-313]), and a traditional custom in Japan, dating from the 18th century, is to eat cooked eel at the end of July. Furthermore, 71% of the eels from the eel farms in Korea ([@b60-jidmm-26-313]) have been reported to carry *E tarda*.

Toward the end of the 1960s in the US, *E tarda* was linked to catfish, mainly in the waters of Arkansas, Mississippi, Texas and Louisiana ([@b61-jidmm-26-313]). Despite the small number of cases in the current study, approximately one-half of the cases occurred around the Gulf of Mexico, which receives a supply of nutrient-rich water from several rivers. Individuals residing in these areas may be exposed to high concentrations of *E tarda* through the water or contaminated food. According to data from the National Fisheries Institute, tilapia, pangasius and catfish are consumed in the US. They are farmed in fresh water and 79% of already-dressed catfish in the US carry *E tarda* ([@b62-jidmm-26-313]). Given the collective findings of the available literature, we suspect that dietary exposures also affect the risk for ETB.

Little is known about the recent prevalence of *E tarda* colonization in healthy individuals; no recent data are available from large-scale studies in any country. A study conducted in the 1970s ([@b7-jidmm-26-313]), is one of the few to report that only 26 of 353,600 Japanese individuals were healthy carriers of *E tarda*. We suspect that the rate of colonization in stool appears to be high among individuals in areas with a high consumption of raw fish contaminated with *E tarda*. The colonization rate in humans may be affected by changes in dietary habits and increased travel, and the use of novel techniques, such as matrix-assisted laser desorption ionization--time of flight mass spectrometry, may improve identification of *E tarda*, which was previously underestimated.

Trimethoprim/sulfamethoxazole-resistant *E tarda* has been clinically isolated in a pediatric patient with X-linked chronic granulomatous disease and osteomyelitis in Japan ([@b63-jidmm-26-313]). No multidrug-resistant strains of *E tarda* were found in the current study. There are several studies showing at least 90% of *E tarda* strains to be colistin resistant. Natural resistance of *E tarda* to colistin or polymyxin B has been suggested, but its mechanism was unelucidated ([@b64-jidmm-26-313]). Feedstuffs for domesticated animals are exposed to colisin in Japan ([@b65-jidmm-26-313]) and some European countries. Antibiotic resistance in *E tarda* may emerge as an issue related to environmental antibiotic exposure in food production. Geographical differences among the Republic of China (Taiwan) and the US in the antimicrobial susceptibility of *E tarda,* isolated from food-producing animals, have been previously described ([@b66-jidmm-26-313]). Seasonal distribution of human *E tarda* gastroenteritis has not been previously demonstrated ([@b9-jidmm-26-313]). In addition, information has not been available regarding the time of year for extraintestinal *E tarda* infections in previously reported cases. The results of the current review suggest that there may, in fact, be a seasonal distribution of ETB, and exposure to higher concentrations of *E tarda* in the warmer temperatures of the summer months may increase the risk for ETB ([@b61-jidmm-26-313]). For example, Eastern Asia, which includes Japan and the Republic of China (Taiwan), and the states of the US near the Gulf of Mexico, reported the highest rates of ETB and belong to climates that are similar -- humid and subtropical.

In addition, dietary customs vary according to geographical region. Therefore, dietary factors may play a role in the geographical or seasonal distributions of ETB.

Taking all of this into account, we propose two reasons for the high prevalence of ETB in Japan. The first is that Japan is geographically rich in brackish water areas and rivers. Second, the Japanese consume a relatively large amount of raw seafood, which may be contaminated with *E tarda*.

The present review had limitations. One was the retrospective nature of the data, including the use of previously reported literature and only five recent cases from our institute. Fourteen of 72 cases from the literature were described only in the Japanese language. Therefore, publication and resource bias may have affected our results. The second limitation is that we focused on the results of blood cultures; however, sensitivity of blood cultures may vary during a long study period.

CONCLUSIONS
===========

ETB may be categorized as a severe food- and waterborne infection similar to *Aeromonas*, *Vibrio* and *Salmonella* (typhoid fever) infections, which result in high mortality in patients with severe underlying diseases such as liver cirrhosis. Geographical and seasonal distributions may characterize ETB. The clinical epidemiology, including dietary risk factors and the current incidence of ETB should be further established.
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###### 

Clinical characteristics of 77 patients with *Edwardsiella tarda* bacteremia (ETB)

                                                   **Overall n (%)**                 **Survived, n**   **Died, n**   **Univariate analysis**   **Multivariate analysis**   **P**
  ------------------------------------------------ --------------------------------- ----------------- ------------- ------------------------- --------------------------- ---------
  **Cases, n**                                     77                                44                33                                                                  
  **Age, years, mean (range) OR mean ± SD**        61 (2 days -- 101 years)          54.02±26.2        55.9±24.4     0.75                                                  
  \>65 years of age                                31 (40.3)                         17                14            0.818                                                 
  \<1 year of age                                  6 (7.8)                           3                 3             1                                                     
  **Female sex**                                   30 (39.0)                         20                10            0.166                                                 
  **Underlying diseases**                                                                                                                                                  
  Cancer                                           29 (37.7)                         13                16            1                                                     
    Hepatobiliary cancer                           17 (22.1)                         6                 11            0.0531                    3.2 (0.76 -- 13.4)          0.111
    Gastric/colon cancer                           5 (6.5)                           3                 2             1                                                     
  Noncancer                                                                                                                                                                
    Liver cirrhosis                                13 (16.9)                         2                 11            0.000567                  12.0 (2.46 -- 58.6)         0.00213
    Galbladder stone, chorecystitis                21 (27.3)                         16                5             0.0434                    0.351 (0.104 -- 1.19)       0.093
    Diabetes                                       7 (9.1)                           2                 5             0.131                                                 
  Complication of ETB                                                                                                                                                      
    Meningitis                                     4 (5.2)                           1                 3             0.308                                                 
    Liver abscesss                                 10 (13.0)                         7                 3             0.502                                                 
    Diarrhea                                       19 (24.7)                         13                6             0.295                                                 
    Soft tissue infection                          18 (23.4)                         7                 11            0.103                                                 
    Intrauterine infection                         3 (3.9)                           3                 0             0.3498                                                
    No complication                                35 (45.5)                         21                14            0.817                                                 
  **Antimicrobial agents**                                                                                                                                                 
  Penicillins                                      19 (24.7)                         12                7             0.398                                                 
  Cepharosporins                                   26 (33.8)                         15                11            0.781                                                 
  Carbapebens                                      8 (10.4)                          4                 4             1                                                     
  Others (eg, aminoglycosides)                     16 (20.8)                         10                6             0.104                                                 
  **Behavior/dietary risk factors**                                                                                                                                        
  Alcoholism                                       5 (6.5)                           3                 2             1                                                     
  Exposure                                                                                                                                                                 
    To raw food                                    8 (10.4)                          6                 2             0.454                                                 
    To fresh or marine water, animal feces         10 (13.0)                         6                 4             1                                                     
  **Geographical area**                                                                                                                                                    
  Japan                                            35 (45.5)                         19                16            0.653                                                 
  United States (US)                               12 (15.6)                         9                 3             0.216                                                 
    States around the Gulf of Mexico               5 (6.5)                           4                 1             1                                                     
  Republic of China (Taiwan)                       10 (13.0)                         6                 4             1                                                     
  Other region (Not Japan, US, Taiwan)             19 (24.7)                         9                 10            0.104                                                 
  **Season of onset (northern hemisphere)**                                                                                                                                
  Summer (June to November)                        18 (23.4)                         13                5             0.117                                                 
  **Period of time from onset to patient dying**   20 h -- 61 days (median 8 days)                                                                                         

###### 

Antimicrobial susceptibility of *Edwardsiella tarda* isolated from blood culture; five cases from Tokyo Women's Medical University (TWMU; Tokyo, Japan) and eight cases from the literature

  **Age, years/sex**   **Underlying disease(s)**   **Complication**   **Exposure/dietary risk**   **Minimum inhibitory concentration (MIC), mg/L**   **TWMU case or reference**   **Country**   **Year**                                                                      
  -------------------- --------------------------- ------------------ --------------------------- -------------------------------------------------- ---------------------------- ------------- ------------ ------------ -------- ----- ----------- -------- --------------- ------
  88/female            GBS                         Cholecystitis      ND                          \<2                                                \<2                          \<8           \<1          \<1          \<0.5    \<2   16 (R)      TWMU-1   Japan           2004
  80/male              LC, HCC                     EC                 ND                          \<2                                                \<2                          \<8           \<1          \<1          \<0.5    \<2   24 (R)      TWMU-2   Japan           2004
  84/male              BCa                         Cholecystitis      ND                          \<4                                                \<4                          \<8           \<1          \<1          \<2      \<2   32 (R)      TWMU-3   Japan           2010
  80/female            PCa                         Liver abscess      ND                          \<4                                                \<4                          \<8           \<1          \<1          \<2      \<2   0.125 (S)   TWMU-4   Japan           2013
  46/female            Ce-Ca                       EC                 Sushi                       \<4                                                \<4                          \<8           \<1          \<1          \<2      \<2   32 (R)      TWMU-5   Japan           2013
  14/female            none                        Liver abscess      Immigrant                   S                                                  ND                           ND            ND           ND           ND       ND    R           13       Thailand        1969
  46/male              none                        EC                 Travel to Mexico            0.25                                               1 (cefalothin)               ND            ND           0.25         ND       ND    R           18       United States   1980
  39/male              Alcoholism                  EP, DC             ND                          S                                                  S                            S             S            S            S        S     ND          41       Japan           1988
  67/male              HCC, LC                     NF                 ND                          S                                                  S                            S             S            S            S        S     ND          42       Japan           1996
  76/male              DM, HCC                     Liver abscess      Sushi                       ND                                                 \<8                          \<8 (CAZ)     \<1 (MEPM)   \<16 (AMK)   \<2      ND    ND          51       Japan           2011
  21/female            SCA                         None               ND                          \<2                                                \<4                          \<0.5         \<1          2            \<0.25   \<2   ND          39       Columbia        2008
  46/female            SLE                         PID                ND                          \<2                                                \<4                          \<1           \<1          \<1          \<0.12   ND    ND          53       Japan           2012
  67/female            NHL                         NF                 ND                          \<4                                                \<4                          \<8           \<1          \<1          \<1      \<2   ND          52       Japan           2012

ABPC Ampicillin; AMK Amoxicillin; BCa Bile duct cancer; CAZ Ceftazidime; Ce-Ca Cervical cancer; CEZ Cefazolin; CTX Cefotaxime; DC Discitis; DM Diabetes mellitus; EC Endstage cancer; EP Endophthalmitis; GBS Gallbladder stone; GM Gentamicin; HCC Hepatiocellular carcinoma; IPM/CS Imipenem cilastatin; LC Liver cirrhosis; LVFX Levofloxacin; MEPM Meropenem; ND Not described; NF Neurofibromatosis; NHL Non-Hodgkin lymphoma; PCa Pancreatic cancer; PID Pelvic inflammatory disease; R Resistant (MIC not described); S Susceptible (MIC not described); SCA Sickle cell anemia; SLE Systemic lupus erythematosus; TMP-SMX Trimethoprim/sulfamethoxazole
